| ■ 영문 제목 : Global Ibrutinib API Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00651 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 98 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 화학, 재료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 이브루티닙 API의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (순도 ≥98%, 순도 <98%)와 용도별 시장규모 (이브루티닙 캡슐, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 이브루티닙 API 시장 점유율 - 지역별 이브루티닙 API 시장규모 - 주요지역의 종류별 시장규모 (순도 ≥98%, 순도 <98%) - 주요지역의 용도별 시장규모 (이브루티닙 캡슐, 기타) - 미주의 이브루티닙 API 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 이브루티닙 API 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 이브루티닙 API 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 이브루티닙 API 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 이브루티닙 API 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Dr. Reddy’s Laboratories Ltd., Teva API, Shilpa Medicare Limited, Wisdom Pharmaceutical Co., Ltd., ScinoPharm Taiwan, Ltd, Sun Pharmaceutical Industries Ltd., Haoyuan Chemexpress - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Ibrutinib API will have significant change from previous year. By the most conservative estimates of global Ibrutinib API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Ibrutinib API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Ibrutinib API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Purity≥98%
Purity<98%
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Ibrutinib Capsules
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Dr. Reddy’s Laboratories Ltd.
Teva API
Shilpa Medicare Limited
Wisdom Pharmaceutical Co., Ltd.
ScinoPharm Taiwan, Ltd
Sun Pharmaceutical Industries Ltd.
Haoyuan Chemexpress
1 Scope of the Report 2 Executive Summary Table 1. Ibrutinib API Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Purity≥98% Table 3. Major Players of Purity<98% Table 4. Global Ibrutinib API Sales by Type (2016-2021) & (Ton) Table 5. Global Ibrutinib API Sales Market Share by Type (2016-2021) Table 6. Global Ibrutinib API Revenue by Type (2016-2021) & ($ million) Table 7. Global Ibrutinib API Revenue Market Share by Type (2016-2021) Table 8. Global Ibrutinib API Sale Price by Type (2016-2021) Table 9. Global Ibrutinib API Sales by Application (2016-2021) & (Ton) Table 10. Global Ibrutinib API Sales Market Share by Application (2016-2021) Table 11. Global Ibrutinib API Value by Application (2016-2021) Table 12. Global Ibrutinib API Revenue Market Share by Application (2016-2021) Table 13. Global Ibrutinib API Sale Price by Application (2016-2021) Table 14. Global Ibrutinib API Sales by Company (2019-2021) & (Ton) Table 15. Global Ibrutinib API Sales Market Share by Company (2019-2021) Table 16. Global Ibrutinib API Revenue by Company (2019-2021) ($ Millions) Table 17. Global Ibrutinib API Revenue Market Share by Company (2019-2021) Table 18. Global Ibrutinib API Sale Price by Company (2019-2021) Table 19. Key Manufacturers Ibrutinib API Producing Area Distribution and Sales Area Table 20. Players Ibrutinib API Products Offered Table 21. Ibrutinib API Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Ibrutinib API Sales by Region (2016-2021) (Ton) Table 25. Global Ibrutinib API Sales Market Share by Region (2016-2021) Table 26. Global Ibrutinib API Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Ibrutinib API Revenue Market Share by Region (2016-2021) Table 28. Americas Ibrutinib API Sales by Country (2016-2021) & (Ton) Table 29. Americas Ibrutinib API Sales Market Share by Country (2016-2021) Table 30. Americas Ibrutinib API Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Ibrutinib API Revenue Market Share by Country (2016-2021) Table 32. Americas Ibrutinib API Sales by Type (2016-2021) & (Ton) Table 33. Americas Ibrutinib API Sales Market Share by Type (2016-2021) Table 34. Americas Ibrutinib API Sales by Application (2016-2021) & (Ton) Table 35. Americas Ibrutinib API Sales Market Share by Application (2016-2021) Table 36. APAC Ibrutinib API Sales by Region (2016-2021) & (Ton) Table 37. APAC Ibrutinib API Sales Market Share by Region (2016-2021) Table 38. APAC Ibrutinib API Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Ibrutinib API Revenue Market Share by Region (2016-2021) Table 40. APAC Ibrutinib API Sales by Type (2016-2021) & (Ton) Table 41. APAC Ibrutinib API Sales Market Share by Type (2016-2021) Table 42. APAC Ibrutinib API Sales by Application (2016-2021) & (Ton) Table 43. APAC Ibrutinib API Sales Market Share by Application (2016-2021) Table 44. Europe Ibrutinib API Sales by Country (2016-2021) & (Ton) Table 45. Europe Ibrutinib API Sales Market Share by Country (2016-2021) Table 46. Europe Ibrutinib API Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Ibrutinib API Revenue Market Share by Country (2016-2021) Table 48. Europe Ibrutinib API Sales by Type (2016-2021) & (Ton) Table 49. Europe Ibrutinib API Sales Market Share by Type (2016-2021) Table 50. Europe Ibrutinib API Sales by Application (2016-2021) & (Ton) Table 51. Europe Ibrutinib API Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Ibrutinib API Sales by Country (2016-2021) & (Ton) Table 53. Middle East & Africa Ibrutinib API Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Ibrutinib API Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Ibrutinib API Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Ibrutinib API Sales by Type (2016-2021) & (Ton) Table 57. Middle East & Africa Ibrutinib API Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Ibrutinib API Sales by Application (2016-2021) & (Ton) Table 59. Middle East & Africa Ibrutinib API Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Ibrutinib API Table 61. Key Application and Potential Industries of Ibrutinib API Table 62. Key Challenges of Ibrutinib API Table 63. Key Trends of Ibrutinib API Table 64. Ibrutinib API Distributors List Table 65. Ibrutinib API Customer List Table 66. Global Ibrutinib API Sales Forecast by Region (2021-2026) & (Ton) Table 67. Global Ibrutinib API Consumption Market Forecast by Region Table 68. Global Ibrutinib API Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Ibrutinib API Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Ibrutinib API Sales Forecast by Country (2021-2026) & (Ton) Table 71. Americas Ibrutinib API Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Ibrutinib API Sales Forecast by Region (2021-2026) & (Ton) Table 73. APAC Ibrutinib API Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Ibrutinib API Sales Forecast by Country (2021-2026) & (Ton) Table 75. Europe Ibrutinib API Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Ibrutinib API Sales Forecast by Country (2021-2026) & (Ton) Table 77. Middle East & Africa Ibrutinib API Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Ibrutinib API Sales Forecast by Type (2021-2026) & (Ton) Table 79. Global Ibrutinib API Sales Market Share Forecast by Type (2021-2026) Table 80. Global Ibrutinib API Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Ibrutinib API Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Ibrutinib API Sales Forecast by Application (2021-2026) & (Ton) Table 83. Global Ibrutinib API Sales Market Share Forecast by Application (2021-2026) Table 84. Global Ibrutinib API Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Ibrutinib API Revenue Market Share Forecast by Application (2021-2026) Table 86. Dr. Reddy’s Laboratories Ltd. Basic Information, Ibrutinib API Manufacturing Base, Sales Area and Its Competitors Table 87. Dr. Reddy’s Laboratories Ltd. Ibrutinib API Product Offered Table 88. Dr. Reddy’s Laboratories Ltd. Ibrutinib API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 89. Dr. Reddy’s Laboratories Ltd. Main Business Table 90. Dr. Reddy’s Laboratories Ltd. Latest Developments Table 91. Teva API Basic Information, Ibrutinib API Manufacturing Base, Sales Area and Its Competitors Table 92. Teva API Ibrutinib API Product Offered Table 93. Teva API Ibrutinib API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 94. Teva API Main Business Table 95. Teva API Latest Developments Table 96. Shilpa Medicare Limited Basic Information, Ibrutinib API Manufacturing Base, Sales Area and Its Competitors Table 97. Shilpa Medicare Limited Ibrutinib API Product Offered Table 98. Shilpa Medicare Limited Ibrutinib API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 99. Shilpa Medicare Limited Main Business Table 100. Shilpa Medicare Limited Latest Developments Table 101. Wisdom Pharmaceutical Co., Ltd. Basic Information, Ibrutinib API Manufacturing Base, Sales Area and Its Competitors Table 102. Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Product Offered Table 103. Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 104. Wisdom Pharmaceutical Co., Ltd. Main Business Table 105. Wisdom Pharmaceutical Co., Ltd. Latest Developments Table 106. ScinoPharm Taiwan, Ltd Basic Information, Ibrutinib API Manufacturing Base, Sales Area and Its Competitors Table 107. ScinoPharm Taiwan, Ltd Ibrutinib API Product Offered Table 108. ScinoPharm Taiwan, Ltd Ibrutinib API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 109. ScinoPharm Taiwan, Ltd Main Business Table 110. ScinoPharm Taiwan, Ltd Latest Developments Table 111. Sun Pharmaceutical Industries Ltd. Basic Information, Ibrutinib API Manufacturing Base, Sales Area and Its Competitors Table 112. Sun Pharmaceutical Industries Ltd. Ibrutinib API Product Offered Table 113. Sun Pharmaceutical Industries Ltd. Ibrutinib API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 114. Sun Pharmaceutical Industries Ltd. Main Business Table 115. Sun Pharmaceutical Industries Ltd. Latest Developments Table 116. Haoyuan Chemexpress Basic Information, Ibrutinib API Manufacturing Base, Sales Area and Its Competitors Table 117. Haoyuan Chemexpress Ibrutinib API Product Offered Table 118. Haoyuan Chemexpress Ibrutinib API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 119. Haoyuan Chemexpress Main Business Table 120. Haoyuan Chemexpress Latest Developments List of Figures Figure 1. Picture of Ibrutinib API Figure 2. Ibrutinib API Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Ibrutinib API Sales Growth Rate 2016-2026 (Ton) Figure 7. Global Ibrutinib API Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Ibrutinib API Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Purity≥98% Figure 10. Product Picture of Purity<98% Figure 11. Global Ibrutinib API Sales Market Share by Type in 2020 Figure 12. Global Ibrutinib API Revenue Market Share by Type (2016-2021) Figure 13. Ibrutinib API Consumed in Ibrutinib Capsules Figure 14. Global Ibrutinib API Market: Ibrutinib Capsules (2016-2021) & (Ton) Figure 15. Ibrutinib API Consumed in Others Figure 16. Global Ibrutinib API Market: Others (2016-2021) & (Ton) Figure 17. Global Ibrutinib API Sales Market Share by Application (2016-2021) Figure 18. Global Ibrutinib API Revenue Market Share by Application in 2020 Figure 19. Ibrutinib API Revenue Market by Company in 2020 ($ Million) Figure 20. Global Ibrutinib API Revenue Market Share by Company in 2020 Figure 21. Global Ibrutinib API Sales Market Share by Regions (2016-2021) Figure 22. Global Ibrutinib API Revenue Market Share by Region in 2020 Figure 23. Americas Ibrutinib API Sales 2016-2021 (Ton) Figure 24. Americas Ibrutinib API Revenue 2016-2021 ($ Millions) Figure 25. APAC Ibrutinib API Sales 2016-2021 (Ton) Figure 26. APAC Ibrutinib API Revenue 2016-2021 ($ Millions) Figure 27. Europe Ibrutinib API Sales 2016-2021 (Ton) Figure 28. Europe Ibrutinib API Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Ibrutinib API Sales 2016-2021 (Ton) Figure 30. Middle East & Africa Ibrutinib API Revenue 2016-2021 ($ Millions) Figure 31. Americas Ibrutinib API Sales Market Share by Country in 2020 Figure 32. Americas Ibrutinib API Revenue Market Share by Country in 2020 Figure 33. Americas Ibrutinib API Sales Market Share by Type in 2020 Figure 34. Americas Ibrutinib API Sales Market Share by Application in 2020 Figure 35. United States Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Ibrutinib API Sales Market Share by Region in 2020 Figure 40. APAC Ibrutinib API Revenue Market Share by Regions in 2020 Figure 41. APAC Ibrutinib API Sales Market Share by Type in 2020 Figure 42. APAC Ibrutinib API Sales Market Share by Application in 2020 Figure 43. China Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 47. India Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Ibrutinib API Sales Market Share by Country in 2020 Figure 50. Europe Ibrutinib API Revenue Market Share by Country in 2020 Figure 51. Europe Ibrutinib API Sales Market Share by Type in 2020 Figure 52. Europe Ibrutinib API Sales Market Share by Application in 2020 Figure 53. Germany Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 54. France Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Ibrutinib API Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Ibrutinib API Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Ibrutinib API Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Ibrutinib API Sales Market Share by Application in 2020 Figure 62. Egypt Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Ibrutinib API Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 이브루티닙 API 시장예측 2021년-2026년] (코드 : LPI-2201K00651) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 이브루티닙 API 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |